MAPT and Alzheimer disease: Truncation of tau at Asp402, a putative caspase-6 cleavage site, has also been identified in transgenic animals, and Asp25 cleavage of tau, possibly due to the action of caspase-3 has also been detected in AD brain [185, 418].